Atherosclerosis, a dominant and growing cause of death and disability worldwide, involves
inflammation from its inception to the emergence of complications. Targeting inflammatory …

The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Risk of MI after Acute Infection Among patients who are hospitalized for pneumococcal
pneumonia, the incidence of myocardial infarction is 7 to 8%. The true incidence of …

Abstract Severe Acute Respiratory Syndrome–Coronavirus-2 is responsible for the current
pandemic that has led to more than 10 million confirmed cases of Coronavirus Disease-19 …

Platelets are increasingly being recognized for playing roles beyond thrombosis and
hemostasis. Today we know that they mediate inflammation by direct interactions with innate …

Background. Previous reports suggest that community-acquired pneumonia (CAP) is
associated with an enhanced risk of cardiovascular complications. However, a …

Community acquired pneumonia remains a common cause of morbidity and mortality.
Usually, the causal organism is not identified and treatment remains empiric. Recent …

Despite treatment advances for sepsis and pneumonia, significant improvements in outcome
have not been realized. Antiplatelet therapy may improve outcome in pneumonia and …

Gut microbiota has been recently established to have a contributory role in the development
of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing …

Die vorliegende Leitlinie umfasst ein neues und aktualisiertes Konzept der Behandlung und
Prävention von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die …